Literature DB >> 28300916

Porokeratosis simulating Bowen's disease on dermoscopy.

Alzinira Sousa Herênio1, Silvana Maria de Morais Cavalcanti2, Emmanuel Rodrigues de França2, Clarissa Marques Maranhão1, Eliane Ruth Barbosa de Alencar2.   

Abstract

Porokeratosis is a disorder of epidermal keratinization characterized by the presence of annular hyperkeratotic plaques. Its etiopathogenesis is not yet fully understood, but a relationship with immunosuppression has been reported. Dermoscopic examination revealed a classic yellowish-white ring-like structure that resembled "volcanic crater contour" - the so-called cornoid lamella. We describe a case of porokeratosis in a female patient with chronic lymphedema, which was similar to Bowen's disease due to the many glomerular vessels seen on clinical examination and dermoscopy.

Entities:  

Mesh:

Year:  2016        PMID: 28300916      PMCID: PMC5325015          DOI: 10.1590/abd1806-4841.20164479

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Porokeratosis is a disorder of keratinization characterized by annular hyperkeratotic plaques with raised borders.[1] At least five clinical variants are reported in the literature, and all of them share one characteristic, the cornoid lamella, which is a thin column of closely stacked parakeratotic cells in an area of epidermal invagination.[1] An association between porokeratosis and malignancy has been described, including Bowen's disease (BD). Immunosuppression is a risk factor for malignancy.[2] We report a case of porokeratosis in a female patient with chronic lymphedema, which was similar to BD on clinical examination and dermoscopy. BD is an important differential diagnosis in cases of lesions with a glomerular pattern under dermoscopy.

CASE REPORT

A 74-year-old female patient reported a history of an asymptomatic lesion on her left forearm in the last three years. After mastectomy, the patient presented with chronic lymphedema on the affected limb with ipsilateral axillary dissection. The malignant breast tumor was treated with subsequent radiotherapy sessions. Clinical examination revealed a well-defined erythematous plaque with raised borders of approximately 3 cm in diameter on her left forearm (Figures 1 and 2). With dermoscopy we observed homogeneous glomerular vessels throughout the lesion with an erythematous background and keratotic border (Figure 3). BD was a possible diagnosis. Histopathological examination revealed the presence of a cornoid lamella and the absence of cell atypia, thus confirming the diagnosis of porokeratosis (Figure 4).
Figure 1

Lymphedema on the left forearm with an erythematous plaque lesion and keratotic border

Figure 2

Edematous skin with an erythematous plaque lesion and keratotic border on the left forearm

Figure 3

Dermoscopy: presence of abundant glomerular vessels throughout the lesion with an erythematous background and keratotic border

Figure 4

Histopathology: cornoid lamella (black arrow) and absence of cell atypia (HE)

Lymphedema on the left forearm with an erythematous plaque lesion and keratotic border Edematous skin with an erythematous plaque lesion and keratotic border on the left forearm Dermoscopy: presence of abundant glomerular vessels throughout the lesion with an erythematous background and keratotic border Histopathology: cornoid lamella (black arrow) and absence of cell atypia (HE)

DISCUSSION

Porokeratosis was first described by Mibelli and Respighi in 1893.3 It is a disorder of keratinization, and at least five variants are recognized, as follows: 1) porokeratosis of Mibelli; 2) disseminated superficial porokeratosis; 3) disseminated superficial actinic porokeratosis (DSAP); 4) linear porokeratosis; and 5) porokeratosis palmaris et plantaris disseminata.[1] The disease predominates in males, and the lower limbs are the sites most commonly affected in porokeratosis of Mibelli and DSAP.[4] All these variants are associated with the presence of a cornoid lamella (a column of keratotic cells in an area of epidermal invagination seen through histopathology). Porokeratosis may be considered a premalignant lesion, with a risk of change at around 7.5%.[2] Although the clinical presence of a single lesion associated with immunosuppression suggested the diagnosis of porokeratosis of Mibelli, it is worth mentioning that this variant is epidemiologically more common in children and male patients, different from our patient, who is an elderly woman.[5] Dermoscopy is a non-invasive diagnostic method which uses a magnifying lens combined with immersion (use of gel, oil or other liquid) or with polarized light filters to reduce refraction. It allows the visualization of pigmented and vascular structures extending from the stratum corneum to the papillary dermis.[6] Under dermoscopy, porokeratosis typically reveals a yellowish-white ridge-like structure showing a pale pink area of central atrophy that resembles volcanic craters. Rare red globular structures may be present, differently from what is observed in squamous cell carcinoma in situ, in which these structures are abundant.[7] Under dermoscopy our patient presented with a keratotic lesion showing many glomerular vessels, compatible with BD symptoms. BD shows a 98% probability of squamous cell carcinoma in situ when glomerular or punctate vessels associated with hyperkeratosis are present.[8] Histopathology was paramount to rule out malignancy due to the absence of atypia and the presence of a cornoid lamella, which led to the diagnosis of porokeratosis. Porokeratosis has been reported in immunocompromised subjects such as patients who have undergone transplant, those with hematological neoplasms and those who have undergone chemotherapy, previous irradiation, and corticotherapy.[9] This is due to the growth of abnormal epidermal clones, a fact confirmed by lesion improvement after the immunosuppressing factor ceases to exist.[10] Because lymphedema causes or results from local immunosuppression, it is also a risk factor for the development of porokeratosis. The case herein described involves the presence of a lymphedema on the upper left limb after mastectomy with ipsilateral axillary dissection and subsequent radiotherapy sessions to treat a malignant breast tumor, which is a known risk factor for porokeratosis. Hence, we highlight the importance of this diagnosis in immunosuppressed patients, even if the lesion may suggest neoplastic disease upon clinical examination or dermoscopy. Histopathology is essential to rule out malignancy and confirm possibly unexpected differential diagnoses.
  9 in total

Review 1.  Dermoscopy of pigmented skin lesions.

Authors:  H P Soyer; G Argenziano; S Chimenti; V Ruocco
Journal:  Eur J Dermatol       Date:  2001 May-Jun       Impact factor: 3.328

2.  Dermoscopy for the diagnosis of porokeratosis.

Authors:  Mario Delfino; Giuseppe Argenziano; Massimiliano Nino
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-03       Impact factor: 6.166

3.  Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.

Authors:  Iris Zalaudek; Jason Giacomel; Karin Schmid; Silvia Bondino; Cliff Rosendahl; Stefano Cavicchini; Athanasia Tourlaki; Saturnino Gasparini; Peter Bourne; Jeff Keir; Harald Kittler; Laura Eibenschutz; Caterina Catricalà; Giuseppe Argenziano
Journal:  J Am Acad Dermatol       Date:  2011-08-11       Impact factor: 11.527

4.  Disseminated superficial actinic porokeratosis diagnosed by dermoscopy.

Authors:  Vincenzo Panasiti; Mariarita Rossi; Michela Curzio; Francesca Bruni; Stefano Calvieri
Journal:  Int J Dermatol       Date:  2008-03       Impact factor: 2.736

Review 5.  Porokeratosis and immunosuppression.

Authors:  J Kanitakis; S Euvrard; M Faure; A Claudy
Journal:  Eur J Dermatol       Date:  1998 Oct-Nov       Impact factor: 3.328

6.  Porokeratosis in association with lymphoedema.

Authors:  I C Pearson; N H Cox; L S Ostlere; R A Marsden; P S Mortimer
Journal:  Clin Exp Dermatol       Date:  2005-03       Impact factor: 3.470

Review 7.  Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features.

Authors:  Jean Kanitakis
Journal:  Eur J Dermatol       Date:  2014 Sep-Oct       Impact factor: 3.328

Review 8.  Porokeratosis and cutaneous malignancy. A review.

Authors:  M Sasson; A D Krain
Journal:  Dermatol Surg       Date:  1996-04       Impact factor: 3.398

9.  Disseminated superficial porokeratosis: complete remission subsequent to discontinuation of immunosuppression.

Authors:  D Tsambaos; T Spiliopoulos
Journal:  J Am Acad Dermatol       Date:  1993-04       Impact factor: 11.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.